The influence of hexamethonium intracisternally and of hexamethonium and trimethaphan camphorsulfonate intravenously on the pressor responses to intracisternal veratrine.
D000470:Alkaloids / Q000037:antagonists & inhibitors*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002339:Carotid Arteries / Q000502:physiology; D002490:Central Nervous System / Q000187:drug effects; D002946:Cisterna Magna; D003250:Constriction; D003864:Depression, Chemical; D004285:Dogs; D005260:Female; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D008297:Male; D009538:Nicotine / Q000037:antagonists & inhibitors; D013153:Splanchnic Nerves / Q000502:physiology; D014294:Trimethaphan / Q000494:pharmacology*; D014702:Veratrine / Q000037:antagonists & inhibitors
D000470:Alkaloids; D006584:Hexamethonium Compounds; D014294:Trimethaphan; D009538:Nicotine; D014702:Veratrine